Bluejay Diagnostics (NASDAQ:BJDX) Announces Quarterly Earnings Results

Bluejay Diagnostics (NASDAQ:BJDX) posted its quarterly earnings data on Monday. The company reported ($112.37) earnings per share for the quarter, Zacks reports.

Bluejay Diagnostics Stock Down 2.1 %

NASDAQ BJDX opened at $3.73 on Tuesday. The firm has a market capitalization of $2.06 million, a PE ratio of 0.00 and a beta of 0.38. The stock’s 50 day moving average is $3.84 and its 200 day moving average is $4.49. Bluejay Diagnostics has a twelve month low of $3.03 and a twelve month high of $323.68.

Bluejay Diagnostics Company Profile

Bluejay Diagnostics, Inc, a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components.